ADMA Biologics Inc (NASDAQ:ADMA)

9.45
Delayed Data
As of Jul 02
 -0.05 / -0.53%
Today’s Change
7.51
Today|||52-Week Range
14.00
-15.40%
Year-to-Date

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for ADMA Biologics Inc have a median target of 20.00, with a high estimate of 24.00 and a low estimate of 17.50. The median estimate represents a +111.64% increase from the last price of 9.45.

Analyst Recommendations

The current consensus among 4 polled investment analysts is to Buy stock in ADMA Biologics Inc. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.45
Sales
$1.5M
Reporting Date
Aug 11

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -22.30%
 
 
 
 
 
 
Growthannually -2.00%
 
 
 
 

Sales

Growthquarterly 1.66%
 
 
 
 
 
 
Growthannually 5.73%
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account